Skip to main content

The Cytochrome P450 System in Disease States—A Brief Review

  • Chapter
Book cover A Case Approach to Perioperative Drug-Drug Interactions

Abstract

This chapter briefly discusses the cytochrome P450 system in several disease states, including heart, liver, and kidney failure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kirwan CJ, Lee T, Holt DW, et al. Using midazolam to monitor changes in hepatic drug metabolism in critically ill patients. Intensive Care Med. 2009;35(7):1271–5. Epub 2009 Feb 7.

    Article  PubMed  CAS  Google Scholar 

  2. Kirwan CJ, MacPhee IA, Lee T, et al. Acute kidney injury reduces the hepatic metabolism of midazolam in critically ill patients. Intensive Care Med. 2012;38(1):76–84. Epub 2011 Oct 18.

    Article  PubMed  CAS  Google Scholar 

  3. Zordoky BN, El-Kadi AO. Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure. Curr Drug Metab. 2008;9(2):122–8.

    Article  PubMed  CAS  Google Scholar 

  4. Adedoyin A, Arns PA, Richards WO, et al. Selective effect of liver disease on the activities of specific metabolizing enzymes: investigation of cytochromes P450 2C19 and 2D6. Clin Pharmacol Ther. 1998;64(1):8–17.

    Article  PubMed  CAS  Google Scholar 

  5. Frye RF, Zgheib NK, Matzke GR, et al. Liver disease selectively modulates cytochrome P450–mediated metabolism. Clin Pharmacol Ther. 2006;80(3):235–45.

    Article  PubMed  CAS  Google Scholar 

  6. Chiu KW, Nakano T, Hu TH, et al. Influence of CYP2C19 genotypes on graft pathological findings and postoperative liver function in recipients after living-donor liver transplantation. Ann Transplant. 2010;15(4):38–43.

    PubMed  CAS  Google Scholar 

  7. Chiu KW, Nakano T, Tseng HP, et al. Western blotting analysis for quantitative detection of CYP2C19 expression in liver tissues in the setting of living donor liver transplantation. Hepatogastroenterology. 2012;59(115):805–8.

    PubMed  CAS  Google Scholar 

  8. McCance-Katz EF. Drug interactions associated with methadone, buprenorphine, cocaine, and HIV medications: implications for pregnant women. Life Sci. 2011;88(21–22):953–8.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  9. Madadi P, Avard D, Koren G. Pharmacogenetics of opioids for the treatment of acute maternal pain during pregnancy and lactation. Curr Drug Metab. 2012;13(6):721–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Catherine Marcucci MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Marcucci, C. (2015). The Cytochrome P450 System in Disease States—A Brief Review. In: Marcucci, C., et al. A Case Approach to Perioperative Drug-Drug Interactions. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7495-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7495-1_13

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-7494-4

  • Online ISBN: 978-1-4614-7495-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics